Glenmark Gets USFDA Tentative Nod For Zolmitriptan Orally Disintegrating Tablets - RTT News

(RTTNews) - Glenmark Pharmaceuticals Ltd. said its US subsidiary Glenmark Generics Inc. has obtained tentative approval from US FDA for Zolmitriptan orally disintegrating tablets, its generic version of AstraZeneca's Zomig-ZMT tablets. The tentative ...

Glenmark Generics receives tentative U.S. FDA approval for zolmitriptan orally disintegrating tablets - equitybulls.com

its generic version of AstraZeneca’s Zomig-ZMT® Tablets. The tentative approval is for the 2.5 mg and 5 mg orally disintegrating tablets of zolmitriptan and constitutes one of the first tentative approvals granted by the FDA for a generic ...

Glenmark Generics gets US FDA tentative nod for zolmitriptan tablets - pharmabiz.com

the generic version of AstraZeneca's Zomig-ZMT tablets. The tentative approval is for the 2.5 mg and 5 mg orally disintegrating tablets of zolmitriptan and consitutes one of the first tentative approvals granted by the FDA for a generic vesion of the drug.

Impax Laboratories Reports Adjusted First Quarter 2012 EPS of $0.52; GAAP EPS of $0.18 - Boston Globe

“During the first quarter of 2012, we established the infrastructure to successfully transition the U.S. commercial opportunity for Zomig® from AstraZeneca to our brand division. The transaction was accretive to our first quarter non-GAAP ...

Glenmark gets tentative nod from USFDA for migraine tablets - MSN India

The approval is for zolmitriptan tablets in the strengths of 2.5 mg and 5 mg, Glenmark said. The tablets are generic version of AstraZeneca''s Zomig-ZMT tablets, it added. Earlier in in September 2011, the company had received tentative approval for ...